Dune Part Three science gets graded against real biology and physics as the December 18 film’s new IMAX trailer drops: somatic cell nuclear transfer already clones primates, Gödel’s incompleteness ...
AI is becoming more capable, but its value still depends on the data, questions and decisions behind it. Where is it ...
News: DXC’s new Bengaluru centre reflects India’s expanding role in enterprise modernisation as AI, legacy systems and ...
Velo3D, Inc. ("Velo3D"), a leading metal additive manufacturing technology company, today announced that Mears Machine Corporation ("Mears") has ordered its fifth Velo3D Sapphire® XC metal additive ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results